Home > PE Ratio > GENPHARMASEC

GENPHARMASEC
PE (Price/Earnings) Ratio

The Current P/E Ratio of GENPHARMASEC is 107.25.

Share Price ₹2.2Apr 25,2024
Market Cap ₹122.4 Cr
Earnings-TTM₹1.1 CrTTM-Standalone Results
Price/Earnings107.25xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of GENPHARMASEC

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of GENPHARMASEC is calculated as :

Current Market Cap [ ₹122.4 Cr] as on Apr 25,2024

(/) Earnings [ ₹1.1 Cr] based on TTM-Standalone Results

(=) P/E Ratio [ 107.25x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for GENPHARMASEC , the investors are currently willing to pay 107.25 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of GENPHARMASEC !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of GENPHARMASEC over the last five years.

Historical PE (Price/Earnings) ratio chart of GENPHARMASEC


PE Ratio Performance Analysis for GENPHARMASEC

- GENPHARMASEC 's latest p/e ratio is 107.25x.

- GENPHARMASEC 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 127.90x.

- GENPHARMASEC 's operated at median p/e ratio of 138.15x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, GENPHARMASEC 's p/e ratio peaked in Mar2020 at 278.22x.

- GENPHARMASEC 's p/e ratio hit its five-year low in Mar2022 of 0x.


How does GENPHARMASEC 's P/E Ratio benchmark against top 10 peers in Dyes & Pigments Industry?

Peer Comparison (Dyes & Pigments Industry)Earnings-TTM (Cr)PE RatioMarket Cap
GENPHARMASEC 1.14107.25122.4
SUDARSHAN CHEMICAL INDUSTRIES LTD331.9815.185,038.7
VIDHI SPECIALTY FOOD INGREDIENTS LTD34.7566.212,301.0
KIRI INDUSTRIES LTD-89.81-21.801,958.3
BODAL CHEMICALS LTD7.24138.941,005.8
BHAGERIA INDUSTRIES LTD17.1445.56780.8
SHREE PUSHKAR CHEMICALS & FERTILISERS LTD36.7915.88584.3
ASAHI SONGWON COLORS LTD3.06136.91418.4
PODDAR PIGMENTS LTD27.5313.48371.1
DYNEMIC PRODUCTS LTD3.48104.06361.9
VIPUL ORGANICS LTD2.6090.26234.4

Dyes & Pigments Industry Benchmark (Top 10) PE Analysis vs GENPHARMASEC 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE -21.80x
Max industry PE 138.94x
Median industry PE 66.21x
Average industry PE 64.72x



You may also like the below Video Courses